Drug Pricing
-
U.S. Health Policies Under Scrutiny: Immigration, Drug Pricing, and Access to Care
An in-depth analysis of recent health policies affecting immigration, drug pricing, and access to care, highlighting their implications for public health and equity.
-
AstraZeneca and Trump’s Drug Pricing Deal
AstraZeneca and the Trump administration struck a landmark deal to reduce U.S. drug prices using a ‘most-favored-nation’ pricing model, with major implications for healthcare affordability and pharmaceutical policy.